Skip to main content
About
Executive Team
Board of Directors
How We Operate
Quality
Capabilities
Locations
News
Products
Contract Manufacturing
Investors
Careers
Careers
Benefits
Available Positions
Application
Contact
Contact Us
Locations
News
Overview
News
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Investment Calculator
Analyst Coverage
Financials
Quarterly Results
Annual Reports
SEC Filings
Governance
Governance Documents
Executive Management
Board of Directors
Committee Composition
Resources
Investor FAQs
Information Request Form
Investor Email Alerts
Investor Contacts
Site Search
Normal
Press release year list
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2009
2008
12/11/2014
ANI Pharmaceuticals Presents At Oppenheimer 25th Annual Healthcare Conference
12/10/2014
ANI Pharmaceuticals Announces Closing of 3.00% Convertible Senior Notes and Full Exercise of Over-Allotment Option
12/05/2014
ANI Pharmaceuticals Announces Pricing of Upsized $125 Million Convertible Notes Offering
12/04/2014
ANI Pharmaceuticals, Inc. Announces $100 Million Public Offering of Convertible Notes
11/06/2014
ANI Pharmaceuticals Announces the Launch of Methazolamide Tablets USP
11/03/2014
ANI Pharmaceuticals Reports Record Third Quarter 2014 Financial Results and Year-To-Date Highlights
Download
PDF format download (opens in new window)
Earnings Release Tables
PDF
PDF format download (opens in new window)
10/27/2014
ANI Pharmaceuticals Schedules Conference Call for Third Quarter 2014 Financial Results
08/04/2014
ANI Reports Second Quarter 2014 Financial Results and Year-To-Date Highlights
Download
PDF format download (opens in new window)
Earnings Release Tables
PDF
PDF format download (opens in new window)
08/01/2014
ANI Pharmaceuticals Acquires Vancocin® Capsules and Additional Vancomycin Assets from Shire
07/28/2014
ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results
07/01/2014
ANI Pharmaceuticals Acquires Lithobid® Extended Release Tablets from Noven Therapeutics
06/18/2014
ANI Pharmaceuticals Signs Exclusive License and Supply Agreement with Dexcel Pharma Technologies Ltd.
05/05/2014
ANI Pharmaceuticals Reports Record Net Revenues of $10.9 million, EPS of $0.33, and Adjusted Non-GAAP EBITDA of $4.2 Million for the First Quarter Ended March 31, 2014
Download
PDF format download (opens in new window)
Earnings Release Tables
PDF
PDF format download (opens in new window)
05/01/2014
ANI Pharmaceuticals Expands Product Development Collaboration with Sofgen
04/28/2014
ANI Pharmaceuticals Schedules Conference Call for First Quarter 2014 Financial Results
03/10/2014
ANI Pharmaceuticals Presents at 26th Annual ROTH Conference
03/10/2014
ANI Pharmaceuticals Announces Closing of Public Offering of Common Stock
03/10/2014
ANI Pharmaceuticals Expands Generic Drug Development Agreement with Sterling Pharmaceuticals
03/06/2014
ANI Pharmaceuticals to Present at 26th Annual ROTH Conference
03/05/2014
ANI Pharmaceuticals Announces Pricing of Public Offering of Common Stock
03/04/2014
ANI Pharmaceuticals Announces Proposed Public Offering of Common Stock
02/18/2014
ANI Pharmaceuticals Reports Record Net Revenues of $10.5 million, EPS from continuing operations of $0.35, and Adjusted Non-GAAP EBITDA of $3.9 Million for the Fourth Quarter Ended December 31, 2013
Download
PDF format download (opens in new window)
Earnings Release Tables
PDF
PDF format download (opens in new window)
02/06/2014
ANI Pharmaceuticals Schedules Conference Call for Fourth Quarter and Full Year 2013 Financial Results
01/06/2014
ANI Pharmaceuticals Enters Development Agreement for Generic Drug Product with Sterling Pharmaceutical Services